Capital Analysts LLC’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10K Sell
55
-28
-34% -$5.15K ﹤0.01% 1293
2026
Q1
$15K Sell
83
-28
-25% -$5.9K ﹤0.01% 1192
2025
Q4
$23K Sell
111
-5
-4% -$1.01K ﹤0.01% 1078
2025
Q3
$24K Hold
116
﹤0.01% 1034
2025
Q2
$20K Hold
116
﹤0.01% 1022
2025
Q1
$16K Sell
116
-17
-13% -$2.24K ﹤0.01% 1044
2024
Q4
$17K Buy
133
+17
+15% +$2.53K ﹤0.01% 974
2024
Q3
$19K Buy
+116
New +$17.5K ﹤0.01% 919

Other funds holding THC

Capital Analysts LLC's THC Position: Q2 2026 in Review

Capital Analysts LLC reduced its Tenet Healthcare (THC) stake by 34% in Q2 2026, selling an estimated $5.15K and leaving 55 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #1293.

Capital Analysts LLC first reported a position in THC in Q3 2024 and has held it in 8 quarters since. The position peaked at $24K in Q3 2025. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Capital Analysts LLC held 55 shares of Tenet Healthcare worth $10K as of Q2 2026.
  • Capital Analysts LLC sold 28 Tenet Healthcare shares in Q2 2026, an estimated $5.15K.
  • Tenet Healthcare made up ﹤0.01% of Capital Analysts LLC's portfolio in Q2 2026, its #1293 holding.
  • Capital Analysts LLC first reported a position in Tenet Healthcare in Q3 2024 and has held it in 8 quarters since.
  • Capital Analysts LLC's Tenet Healthcare position peaked at $24K in Q3 2025.
  • 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.